Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis (MS) for the urologist: What should urologists know about MS?
[Antioxidant use as dietary therapy in patients with multiple sclerosis].
Spinal cord ring enhancement in patients with neuromyelitis optica.
Sex-Based Differences in Multiple Sclerosis (MS): Part II: Rising Incidence of Multiple Sclerosis in Women and the Vulnerability of Men to Progression of this Disease.
A rare brain infection with multiple sclerosis dug.
[Multiple sclerosis: socioeconomic effects and impact on quality of life].
Disambiguating the optic nerve from the surrounding cerebrospinal fluid: Application to MS-related atrophy.
Resilience Predicts Functional Outcomes in People Aging with Disability: A Longitudinal Investigation.
Degradation of polyomavirus JC T-antigen by stress involves the LIP isoform of C/EBP.
Investigation-Directed Approach to Inflammatory Optic Neuropathies.
Variability in the Cross-Sectional Area and Narrowing of the Internal Jugular Vein in Patients Without Multiple Sclerosis.
Immune suppression of JC virus gene expression is mediated by SRSF1.
Plasma levels of endothelial and B-cell-derived microparticles are restored by fingolimod treatment in multiple sclerosis patients.
Frequent laboratory abnormalities in CIDP patients.
Anti-aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló's Concentric Lesions.
Determinants of iron accumulation in deep grey matter of multiple sclerosis patients.
Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect.
Transcription factors and th17 cell development in experimental autoimmune encephalomyelitis.
Concomitant neuromyelitis optica and cytomegalovirus-associated retinitis in an immunocompetent female.
Hunting for autoantibodies in multiple sclerosis.
Inhibitory saccadic dysfunction is associated with cerebellar injury in multiple sclerosis.
Spanish consensus on the use of natalizumab (Tysabri(®))-2013.
Microglia - performers of the 21st century.
Co-occurrence of multiple sclerosis and Thomsen's myotonia: a report of two cases.
Amantadine: Multiple Sclerosis-Related Fatigue.
Pages
« first
‹ previous
…
572
573
574
575
576
577
578
579
580
…
next ›
last »